Allogene Therapeutics ALLO
NASDAQ ALLO
$1.62 -0.01 (-0.61%)
At close: Sep 29, 2026 · 4:00 PM EDT

Allogene Therapeutics (ALLO) Total Non-Current Liabilities (2018 - 2026)

Updated

Allogene Therapeutics' Total Non-Current Liabilities was $102.08 million in Q2 2026, down 8.0% from $110.92 million a year earlier but up 1.1% from the prior quarter.

Analysis

Allogene Therapeutics (ALLO) Total Non-Current Liabilities (2018 - 2026) Analysis & Trends

At the end of FY2025, Total Non-Current Liabilities at Allogene Therapeutics came in at $107.56 million, down 9.4% from FY2024.

  • Total Non-Current Liabilities has now declined for three consecutive years, with a five-year compound annual growth rate of -12.6% (FY2020 to FY2025).
  • In earlier years, Total Non-Current Liabilities was $118.77 million in FY2024 (-5.3%), $125.43 million in FY2023 (-15.7%), $148.85 million in FY2022 (+26.3%) and $117.84 million in FY2021 (-44.2%).
  • Quarterly Total Non-Current Liabilities has moved between $100.96 million (Q1 2026) and $152.91 million (Q1 2023) over five years.
  • Compared with a year earlier, Total Non-Current Liabilities has declined for 12 straight quarters, with an average decline of 8.1% over the last eight quarters.
  • The best year-over-year quarter for Total Non-Current Liabilities over five years was Q2 2022 (growth of 46.5%); the worst was Q4 2021 (a decline of 44.2%).
  • Per Business Quant data, ALLO's Total Non-Current Liabilities in the three quarters before Q2 2026 was $100.96 million (Q1 2026), $107.56 million (Q4 2025) and $108.97 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Non-Current Liabilities (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn 105.99 Bn
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn 106.45 Bn
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn 80.25 Bn
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn 48.34 Bn
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn -967.00 Mn
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn 81.11 Bn
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn 36.04 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn 100.86 Bn
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn 5.92 Bn
10 Allogene Therapeutics 562.91 Mn 562.91 Mn - 102.08 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 102.08 Mn
Mar 31, 2026 100.96 Mn
Dec 31, 2025 107.56 Mn
Sep 30, 2025 108.97 Mn
Jun 30, 2025 110.92 Mn
Mar 31, 2025 111.31 Mn
Dec 31, 2024 118.77 Mn
Sep 30, 2024 117.71 Mn
Jun 30, 2024 124.29 Mn
Mar 31, 2024 119.81 Mn
Dec 31, 2023 125.43 Mn
Sep 30, 2023 127.59 Mn
Jun 30, 2023 146.40 Mn
Mar 31, 2023 152.91 Mn
Dec 31, 2022 148.85 Mn
Sep 30, 2022 144.79 Mn
Jun 30, 2022 142.41 Mn
Mar 31, 2022 105.65 Mn
Dec 31, 2021 117.84 Mn
Sep 30, 2021 104.13 Mn
API Access

Allogene Therapeutics Total Non-Current Liabilities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=total-non-current-liabilities&ticker=ALLO&period=max&api_key=YOUR_API_KEY